Menveo 1 vial-a-c-y-w-135-DIP 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW39X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $116,771
Award facts
- Contract value 100% obligated
- $116,771.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $116,771.35 with an ultimate completion date of January 13, 2026, represents a firm fixed-price award to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) for the supply of Menveo vaccine (1 vial, A-C-Y-W-135 formulation, 0.5mL) to the Defense Logistics Agency. The award, made on January 12, 2026, was not set aside and was competitively awarded. The contract will be performed at the company's Conshohocken, Pennsylvania location, which serves as the corporate office for AmerisourceBergen Drug Corp.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. This prime indefinite delivery contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical items such as specialty medications, vaccines, generic and brand-name drugs, and medical supplies. The Defense Logistics Agency's Medical Supply Chain leverages this contract vehicle to fulfill ongoing pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FW39X?
SPE2DR26FW39X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FW39X worth?
The government has obligated $116,771 on SPE2DR26FW39X.
Is contract SPE2DR26FW39X an order under another contract?
Yes. SPE2DR26FW39X is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW39X competed?
The extent of competition for SPE2DR26FW39X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award